1. Home
  2. GLDD vs ESPR Comparison

GLDD vs ESPR Comparison

Compare GLDD & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$15.25

Market Cap

814.6M

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.53

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
ESPR
Founded
1890
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.6M
898.5M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
GLDD
ESPR
Price
$15.25
$3.53
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$20.00
$6.67
AVG Volume (30 Days)
917.5K
5.7M
Earning Date
02-17-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
36.27
N/A
EPS
1.19
N/A
Revenue
$834,599,000.00
$303,802,000.00
Revenue This Year
$13.16
$27.49
Revenue Next Year
$5.14
N/A
P/E Ratio
$12.88
N/A
Revenue Growth
12.53
2.83
52 Week Low
$7.51
$0.69
52 Week High
$16.72
$4.18

Technical Indicators

Market Signals
Indicator
GLDD
ESPR
Relative Strength Index (RSI) 61.88 53.37
Support Level $14.77 $3.06
Resistance Level $16.72 $3.52
Average True Range (ATR) 0.64 0.22
MACD 0.07 0.02
Stochastic Oscillator 59.13 60.89

Price Performance

Historical Comparison
GLDD
ESPR

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: